Literature DB >> 23883518

Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants.

Marc Lipsitch1, Miguel A Hernán.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23883518      PMCID： PMC3792722          DOI： 10.1093/cid/cit481

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials.

Authors:  Miguel A Hernán; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

Review 2.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Authors:  Tom Jefferson; Mark A Jones; Peter Doshi; Chris B Del Mar; Carl J Heneghan; Rokuro Hama; Matthew J Thompson
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18
  2 in total
  7 in total

1.  Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season.

Authors:  Fiona Havers; Brendan Flannery; Jessie R Clippard; Manjusha Gaglani; Richard K Zimmerman; Lisa A Jackson; Joshua G Petrie; Huong Q McLean; Mary Patricia Nowalk; Michael L Jackson; Arnold S Monto; Edward A Belongia; Heather F Eng; Lois Lamerato; Angela P Campbell; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2015-02-25       Impact factor: 9.079

2.  Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015.

Authors:  Grace D Appiah; Sandra S Chaves; Pam D Kirley; Lisa Miller; James Meek; Evan Anderson; Oluwakemi Oni; Patricia Ryan; Seth Eckel; Ruth Lynfield; Marisa Bargsten; Shelley M Zansky; Nancy Bennett; Krista Lung; Christie McDonald-Hamm; Ann Thomas; Diane Brady; Mary L Lindegren; William Schaffner; Mary Hill; Shikha Garg; Alicia M Fry; Angela P Campbell
Journal:  Clin Infect Dis       Date:  2016-11-10       Impact factor: 9.079

3.  Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

Authors:  Fiona Havers; Swathi Thaker; Jessie R Clippard; Michael Jackson; Huong Q McLean; Manjusha Gaglani; Arnold S Monto; Richard K Zimmerman; Lisa Jackson; Josh G Petrie; Mary Patricia Nowalk; Krissy K Moehling; Brendan Flannery; Mark G Thompson; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

4.  Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics.

Authors:  Mark M Tanaka; Benjamin M Althouse; Carl T Bergstrom
Journal:  Evol Med Public Health       Date:  2014-11-05

5.  Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.

Authors:  Sudhir Venkatesan; Puja R Myles; Kirsty J Bolton; Stella G Muthuri; Tarig Al Khuwaitir; Ashish P Anovadiya; Eduardo Azziz-Baumgartner; Tahar Bajjou; Matteo Bassetti; Bojana Beovic; Barbara Bertisch; Isabelle Bonmarin; Robert Booy; Victor H Borja-Aburto; Heinz Burgmann; Bin Cao; Jordi Carratala; Tserendorj Chinbayar; Catia Cilloniz; Justin T Denholm; Samuel R Dominguez; Pericles A D Duarte; Gal Dubnov-Raz; Sergio Fanella; Zhancheng Gao; Patrick Gérardin; Maddalena Giannella; Sophie Gubbels; Jethro Herberg; Anjarath Lorena Higuera Iglesias; Peter H Hoeger; Xiao Yun Hu; Quazi T Islam; Mirela F Jiménez; Gerben Keijzers; Hossein Khalili; Gabriela Kusznierz; Ilija Kuzman; Eduard Langenegger; Kamran B Lankarani; Yee-Sin Leo; Romina P Libster; Rita Linko; Faris Madanat; Efstratios Maltezos; Abdullah Mamun; Toshie Manabe; Gokhan Metan; Auksė Mickiene; Dragan Mikić; Kristin G I Mohn; Maria E Oliva; Mehpare Ozkan; Dhruv Parekh; Mical Paul; Barbara A Rath; Samir Refaey; Alejandro H Rodríguez; Bunyamin Sertogullarindan; Joanna Skręt-Magierło; Ayper Somer; Ewa Talarek; Julian W Tang; Kelvin To; Dat Tran; Timothy M Uyeki; Wendy Vaudry; Tjasa Vidmar; Paul Zarogoulidis; Jonathan S Nguyen-Van-Tam
Journal:  J Infect Dis       Date:  2020-01-14       Impact factor: 5.226

6.  Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine.

Authors:  Scott Epperson; C Todd Davis; Lynnette Brammer; Anwar Isa Abd Elal; Noreen Ajayi; John Barnes; Alicia P Budd; Erin Burns; Peter Daly; Vivien G Dugan; Alicia M Fry; Yunho Jang; Sara Jo Johnson; Krista Kniss; Rebecca Kondor; Lisa A Grohskopf; Larisa Gubareva; Angiezel Merced-Morales; Wendy Sessions; James Stevens; David E Wentworth; Xiyan Xu; Daniel Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-10-11       Impact factor: 17.586

7.  Update: Influenza Activity - United States and Worldwide, May 20-October 13, 2018.

Authors:  Eric J Chow; C Todd Davis; Anwar Isa Abd Elal; Noreen Alabi; Eduardo Azziz-Baumgartner; John Barnes; Lenee Blanton; Lynnette Brammer; Alicia P Budd; Erin Burns; William W Davis; Vivien G Dugan; Alicia M Fry; Rebecca Garten; Lisa A Grohskopf; Larisa Gubareva; Yunho Jang; Joyce Jones; Krista Kniss; Stephen Lindstrom; Desiree Mustaquim; Rachael Porter; Melissa Rolfes; Wendy Sessions; Calli Taylor; David E Wentworth; Xiyan Xu; Natosha Zanders; Jacqueline Katz; Daniel Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-10-26       Impact factor: 17.586
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.